Zinc (Zn) is an essential metal in the body. It binds to many proteins and regulates their functions. In the immune system, it is known that administration of ZnSO4 suppresses T cell activation, but its effects on allergies are still unknown. In this study, we investigated the effects of ZnSO4 administration on allergic reactions using the rat basophilic leukemia cell line, RBL-2H3. ZnSO4 treatment inhibited cell degranulation induced by antigen and IgE stimulation, as well as by A23187, a Ca2+ ionophore. Antigen and IgE stimulation increased mRNA expression of IL-4, IL-13, and COX-2, and ZnSO4 treatment inhibited this expression. The elevation of intracellular Zn concentration and depletion of Zn did not affect degranulation. Phosphorylation of the proteins spleen tyrosine kinase, p38, ERK1/2, JNK, and Akt was increased by antigen stimulation, but ZnSO4 treatment did not inhibit this phosphorylation. ZnSO4 treatment inhibited the elevation of intracellular Ca2+ concentration induced by antigen and IgE stimulation, as well as by A23187. Additionally, ZnSO4 treatment inhibited thapsigargin, a store-operated Ca2+ entry stimulant, from inducing degranulation and increasing intracellular Ca2+ concentration. These data indicate that exogenous Zn2+ possesses a preventive effect on RBL-2H3 activation via inhibition of Ca2+ influx. The effect of Zn may involve Ca2+ release-activated channels. This study suggests that ZnSO4 treatment is valuable in suppressing allergic responses.